Solidigm Introduces the Industry’s Most Advanced PCIe 4.0 SSD Family, Optimized for Cloud and Enterprise Workloads
News highlights Solidigm is adding two new product lines, the D7-P5520 and the D7-P5620, to…
News
Sharp NEC Display Solutions Enhances Digital Cinema Viewing Experiences with New Modular Laser Projectors
Two new projectors provide cinema operators, art houses, and museums with unparalleled image quality while…
Alorica Introduces Connection Hubs Around the World with Its Newest Addition in the Philippines
An Extension of Alorica Anywhere, This New Workforce Optimization Model Provides Additional Flexibility and Enhanced…
May River Capital Announces Creation of New Material Handling Equipment and Industrial Automation Platform, Automated Handling Solutions
CHICAGO–(BUSINESS WIRE)–May River Capital, a Chicago-based private equity firm focused on lower middle market industrial…
Global Telecommunications Artificial Intelligence of Things Market 2022: Edge Architectures, 5G Deployments, and Use Cases for Access to Geolocation Data Will Accelerate TSPs’ AIoT Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Artificial Intelligence of Things (AIoT) in Telecommunications Growth Opportunities” report has been…
Gnani.ai’s assist365™ Low-code Omnichannel Conversational AI Automation Platform V2.0 sees a 3x Rise in Adoption
Offers fast-track automation across 20+ channels in voice and chat with 360-degree Customer Engagement SAN…
AI Transformer Inventors Launch Adept with $65M to Lend a Hand to Knowledge Workers
Adept is building a natural language interface to everyday software tools SAN FRANCISCO–(BUSINESS WIRE)–Adept, a…
Lumos Pharma to Report First Quarter 2022 Financial Results and Host Conference Call on May 10, 2022
AUSTIN, Tex., April 26, 2022 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical…
Editas Medicine Receives FDA Rare Pediatric Disease Designation for EDIT-301 for the Treatment of Beta Thalassemia
CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing…
Taconic Biosciences and Biomodels Establish Microbiome Initiative
Seamless, Comprehensive Capabilities Eliminate Barriers to Microbiome Research RENSSELAER, N.Y., April 26, 2022 (GLOBE NEWSWIRE)…
Harvard Bioscience Introduces SmartStudy™: First of Kind, Next Generation Inhalation System Capability Improves Precision and Drives Growth
Company continues innovating preclinical tools used in new and ongoing small animal research and product…
Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl)
DUBLIN, Ireland and BRIDGEWATER, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
Bioventus Announces $415 Million Offering of Senior Notes
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Galecto Completes Enrollment in Global Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of IPF
GB0139 is Galecto’s proprietary inhaled once-daily small molecule galectin-3 inhibitor GALACTIC-1 trial on track to…
Agenus to Provide Corporate Update and First Quarter 2022 Financial Report
Conference Call on Tuesday, May 10, 2022 at 8:30 a.m. ET LEXINGTON, Mass., April 26,…
ABVC BioPharma Announces Vitargus Phase II Clinical Study Investigator Meeting
FREMONT, CA, April 26, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
Myovant Sciences to Host Fourth Fiscal Quarter and Fiscal Year 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on May 10, 2022
BASEL, Switzerland, April 26, 2022 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV) today announced it will…
SELLAS Life Sciences Launches Expanded Access Program for Galinpepimut-S
Physicians To Have Pre-Approval/Expanded Access to Galinpepimut-S (GPS) for Treatment of Patients with Acute Myeloid…
Panbela Schedules Conference Call on May 12, 2022, to Report 2022 First Quarter Financial Results
MINNEAPOLIS, April 26, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical…
Tarsus Presents Results of Two Studies Highlighting Demodex Blepharitis Patient Impact and Burden at the ASCRS 2022 Annual Meeting
IRVINE, Calif., April 26, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission…